 |
인쇄하기
취소
|
Pfizer Korea outshine GSK in 2006 sales
Pfizer Korea has regained momentum in last year's sales and reaffirmed its industry leadership over GlaxoSmithKline and Sanofi-Aventis Korea.
The sales gap among three foreign-invested pharmaceutical firms is expected to be narrow this year, market experts said.
Pfizer Korea and GSK posted 362.6 billion won and 357.6 billion won, respectively, in sales last year. Sanofi-Aventis Korea's sa...
The sales gap among three foreign-invested pharmaceutical firms is expected to be narrow this year, market experts said.
Pfizer Korea and GSK posted 362.6 billion won and 357.6 billion won, respectively, in sales last year. Sanofi-Aventis Korea's sa...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.